Next-Generation Vaccines  for Animal HEALTH

We use our proprietary vaccine platform technology to develop vaccines against difficult antigens for animal health.

 

We are a service-oriented technology company that works with our partners to develop best in class animal health vaccines with the goal of long-term, joint value creation.


We offer collaborations and license agreements to industrial partners to develop prophylactic and therapeutic vaccines for companion animals and livestock for

 

  • Oncology
  • Immunomodulation
  • Allergy
  • Inflammation
  • Infectious diseases

 

News

June 1, 2017

Angothera is covered in the June 2017 edition of Biopharma Dealmakers, the partnering supplement to Nature Biotechnology and Nature Reviews Drug Discovery

Download
Biopharma Dealmaker Angothera.pdf
Adobe Acrobat Dokument 133.0 KB

 

April 14, 2017

Angothera and The Antibody Lab  collaborate on the rapid development of animal health vaccines

 

Nov 22, 2016

Angothera and OncoQR sign License agreement on veterinary use of S-TIR vaccine technology

 

Sep 1, 2015.

The Antibody Lab GmbH  inlicenses  Angothera's rights to recombinant Secretory Component

The Antibody Lab has signed a license agreement with Angothera GmbH on the use and commercial exploitation of Angothera's IP-Rights on recombinant Secretory Component.